Background: Increasing epidemiologic and experimental evidence supports the role of inorganic arsenic in the development of diabetes. Arsenic in drinking water is a major concern for US populations who live in small rural communities. Prospective evidence and mechanisms for arsenic related diabetes must be investigated. Objective: To evaluate the role of inorganic arsenic exposure and metabolism and gene-arsenic interactions in the development of diabetes, insulin resistance, ? cell dysfunction and the metabolic syndrome among 2,717 Strong Heart Family Study (SHFS) participants e18 year old who were free of diabetes at baseline. Preliminary studies: We have identified an association between urine arsenic concentrations and the prevalence of diabetes in American Indians 45-74 year old from Arizona, Oklahoma and the Dakotas who participated in the Strong Heart Study (SHS). Urine arsenic concentrations and methylation excretion patterns remained constant over a 10-year follow-up. The heritability of the proportion of monomethylarsonate (%MMA) in urine was 0.52. In a small linkage study, we detected potential quantitative trait loci associated with %MMA in areas of the genome close to methyltransferase genes. Design and setting: The SHFS is a population- based prospective family study that recruited parents, spouses, offspring, spouses of offspring and grandchildren of SHS participants in 1998-2005. Demographic, lifestyle and medical information and measures of fasting glucose and insulin, lipid profile, hypertension endpoints, body mass index, and waist and hip circumferences are available at baseline and follow-up visits through 2011. Urine samples and blood DNA samples were stored at -70oC. Exposure assessment: We will measure total urine arsenic and urine arsenic species concentrations using inductively coupled plasma-mass spectrometry (ICPMS) and high performance liquid chromatography-ICPMS (HPLC-ICPMS), respectively. Genetic assessment: We will prioritize and measure ~1,500 SNPs in candidate genes related to arsenic metabolism and toxicity using a multiplex panel. We will measure SNPs in candidate genes related to diabetes traits using the Metabo-chip, a highly cost- effective candidate gene chip for diabetes and cardiometabolic traits. Statistical analysis: We will use mixed- effect models for binary and linear outcomes to assess the prospective association of urine arsenic species concentrations at baseline with the incidence of diabetes and the metabolic syndrome and changes in the homeostatic model assessment to quantify insulin resistance (HOMA-IR) and ? cell dysfunction (HOMA-B) over time. Gene-arsenic interaction will be estimated using principle component analysis and accounting for population stratification using genomic control. Significance: By investigating the contribution of inorganic arsenic to diabetes, insulin resistance, ? cell dysfunction and the metabolic syndrome and by identifying genetic susceptibility factors, this study can inform the arsenic-diabetes relationship and impact the prevention and control of arsenic exposure in drinking water and food in the US and abroad.
Increasing evidence supports the role of arsenic exposure in the development of diabetes. This study will evaluate the role of arsenic exposure and metabolism and their interaction with genetic markers in the development of diabetes in American Indian communities. This study can provide insight into the arsenic- diabetes relationship and inform public health recommendations for arsenic levels in drinking water and food.
|Nachman, Keeve E; Love, David C; Baron, Patrick A et al. (2017) Nitarsone, Inorganic Arsenic, and Other Arsenic Species in Turkey Meat: Exposure and Risk Assessment Based on a 2014 U.S. Market Basket Sample. Environ Health Perspect 125:363-369|
|Grau-Pérez, Maria; Kuo, Chin-Chi; Spratlen, Miranda et al. (2017) The Association of Arsenic Exposure and Metabolism With Type 1 and Type 2 Diabetes in Youth: The SEARCH Case-Control Study. Diabetes Care 40:46-53|
|Mateen, Farrah J; Grau-Perez, Maria; Pollak, Jonathan S et al. (2017) Chronic arsenic exposure and risk of carotid artery disease: The Strong Heart Study. Environ Res 157:127-134|
|Olmedo, Pablo; Grau-Perez, Maria; Fretts, Amanda et al. (2017) Dietary determinants of cadmium exposure in the Strong Heart Family Study. Food Chem Toxicol 100:239-246|
|Balakrishnan, Poojitha; Vaidya, Dhananjay; Franceschini, Nora et al. (2017) Association of Cardiometabolic Genes with Arsenic Metabolism Biomarkers in American Indian Communities: The Strong Heart Family Study (SHFS). Environ Health Perspect 125:15-22|
|Carroll, Clint R; Noonan, Carolyn; Garroutte, Eva M et al. (2017) Low-level inorganic arsenic exposure and neuropsychological functioning in American Indian elders. Environ Res 156:74-79|
|Spratlen, Miranda Jones; Gamble, Mary V; Grau-Perez, Maria et al. (2017) Arsenic metabolism and one-carbon metabolism at low-moderate arsenic exposure: Evidence from the Strong Heart Study. Food Chem Toxicol 105:387-397|
|Attreed, Sarah E; Navas-Acien, Ana; Heaney, Christopher D (2017) Arsenic and Immune Response to Infection During Pregnancy and Early Life. Curr Environ Health Rep 4:229-243|
|Nigra, Anne E; Nachman, Keeve E; Love, David C et al. (2017) Poultry Consumption and Arsenic Exposure in the U.S. Population. Environ Health Perspect 125:370-377|
|Nigra, Anne E; Sanchez, Tiffany R; Nachman, Keeve E et al. (2017) The effect of the Environmental Protection Agency maximum contaminant level on arsenic exposure in the USA from 2003 to 2014: an analysis of the National Health and Nutrition Examination Survey (NHANES). Lancet Public Health 2:e513-e521|
Showing the most recent 10 out of 36 publications